Renal cancer in recipients of kidney transplant

The aim of our study is to determine characteristics and outcomes of kidney cancer in renal transplant recipients. MEDLINE ® database was searched in June 2015 to identify cases of kidney cancer in renal transplant recipients. We include also a new case. Descriptive statistics were used for analysis...

Full description

Bibliographic Details
Main Authors: Prajwal Dhakal, Smith Giri, Krishmita Siwakoti, Supratik Rayamajhi, Vijaya Raj Bhatt
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Rare Tumors
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/rt/article/view/6550
id doaj-5294ed20b2da407f8bd64f47f2f0199c
record_format Article
spelling doaj-5294ed20b2da407f8bd64f47f2f0199c2020-11-25T03:04:13ZengSAGE PublishingRare Tumors2036-36052036-36132017-03-019110.4081/rt.2017.65503664Renal cancer in recipients of kidney transplantPrajwal Dhakal0Smith Giri1Krishmita Siwakoti2Supratik Rayamajhi3Vijaya Raj Bhatt4Michigan State University, East Lansing, MIThe Yale New Haven Hospital, New Haven, CTUniversity of Tennessee, Memphis, TNMichigan State University, East Lansing, MIUniversity of Nebraska Medical Center, Omaha, NEThe aim of our study is to determine characteristics and outcomes of kidney cancer in renal transplant recipients. MEDLINE ® database was searched in June 2015 to identify cases of kidney cancer in renal transplant recipients. We include also a new case. Descriptive statistics were used for analysis. Forty-eight (48) recipients reported in 25 papers met the eligibility criteria. The median age was 47 years (range 9-66); 27% were females. Chronic glomerulonephritis, cystic kidney disease and hypertension were common indications for renal transplant. Among donors 24% were females and the median age was 52.5 years (17- 73); 62% of kidney cancers were donor-derived. The median interval between transplant and cancer diagnosis was shorter for cancer of recipient versus donor origin (150 vs. 210 days). Clear cell carcinoma was diagnosed in 17%. 25% had metastasis at diagnosis. Kidney explantation or excision was done in 90% and 84% of cases with and without metastasis respectively. The median survival was 72 months. Actuarial 1-year and 5-year survival rates were 73.4% and 55.1% respectively. Among the recipients from 7 donors who subsequently developed malignancy, 57% were dead within a year. Kidney transplant recipients have a small risk of kidney cancer, which affects younger patients and occurs within a year of transplant, likely due to immunosuppression. Whether the use of older donors may increase the likelihood needs further investigation. The presence of metastasis, explantation or excision of affected kidney and development of cancer in donors predict outcomes. The results may guide patient education and informed decision-making.http://www.pagepress.org/journals/index.php/rt/article/view/6550Kidney cancertransplantkidney transplantrecipients
collection DOAJ
language English
format Article
sources DOAJ
author Prajwal Dhakal
Smith Giri
Krishmita Siwakoti
Supratik Rayamajhi
Vijaya Raj Bhatt
spellingShingle Prajwal Dhakal
Smith Giri
Krishmita Siwakoti
Supratik Rayamajhi
Vijaya Raj Bhatt
Renal cancer in recipients of kidney transplant
Rare Tumors
Kidney cancer
transplant
kidney transplant
recipients
author_facet Prajwal Dhakal
Smith Giri
Krishmita Siwakoti
Supratik Rayamajhi
Vijaya Raj Bhatt
author_sort Prajwal Dhakal
title Renal cancer in recipients of kidney transplant
title_short Renal cancer in recipients of kidney transplant
title_full Renal cancer in recipients of kidney transplant
title_fullStr Renal cancer in recipients of kidney transplant
title_full_unstemmed Renal cancer in recipients of kidney transplant
title_sort renal cancer in recipients of kidney transplant
publisher SAGE Publishing
series Rare Tumors
issn 2036-3605
2036-3613
publishDate 2017-03-01
description The aim of our study is to determine characteristics and outcomes of kidney cancer in renal transplant recipients. MEDLINE ® database was searched in June 2015 to identify cases of kidney cancer in renal transplant recipients. We include also a new case. Descriptive statistics were used for analysis. Forty-eight (48) recipients reported in 25 papers met the eligibility criteria. The median age was 47 years (range 9-66); 27% were females. Chronic glomerulonephritis, cystic kidney disease and hypertension were common indications for renal transplant. Among donors 24% were females and the median age was 52.5 years (17- 73); 62% of kidney cancers were donor-derived. The median interval between transplant and cancer diagnosis was shorter for cancer of recipient versus donor origin (150 vs. 210 days). Clear cell carcinoma was diagnosed in 17%. 25% had metastasis at diagnosis. Kidney explantation or excision was done in 90% and 84% of cases with and without metastasis respectively. The median survival was 72 months. Actuarial 1-year and 5-year survival rates were 73.4% and 55.1% respectively. Among the recipients from 7 donors who subsequently developed malignancy, 57% were dead within a year. Kidney transplant recipients have a small risk of kidney cancer, which affects younger patients and occurs within a year of transplant, likely due to immunosuppression. Whether the use of older donors may increase the likelihood needs further investigation. The presence of metastasis, explantation or excision of affected kidney and development of cancer in donors predict outcomes. The results may guide patient education and informed decision-making.
topic Kidney cancer
transplant
kidney transplant
recipients
url http://www.pagepress.org/journals/index.php/rt/article/view/6550
work_keys_str_mv AT prajwaldhakal renalcancerinrecipientsofkidneytransplant
AT smithgiri renalcancerinrecipientsofkidneytransplant
AT krishmitasiwakoti renalcancerinrecipientsofkidneytransplant
AT supratikrayamajhi renalcancerinrecipientsofkidneytransplant
AT vijayarajbhatt renalcancerinrecipientsofkidneytransplant
_version_ 1724682229232173056